KLS-GABA 40mg-17mg clinical trials

A phase 2, multicenter, randomized, double blind, active controlled, parallel group study assessing the analgesic effect and safety of two doses of DFL24412 in patients with chronic low back pain compared to Ketoprofen Lysine Salt (KLS)

This study is testing different doses of a new medicine (DFL24412) for long-lasting lower back pain. Researchers want to see if it reduces pain and is safe, comparing it to a common painkiller called Ketoprofen Lysine Salt.